Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2000
11/22/2000EP1053323A2 Human receptor proteins
11/22/2000EP1053321A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
11/22/2000EP1053320A2 Human transport-associated molecules
11/22/2000EP1053318A2 Cdnas encoding secreted proteins
11/22/2000EP1053308A1 Dendritic enriched secreted lymphocyte activation molecule
11/22/2000EP1053307A1 Podocalyxin like sialomucins having selectin ligand activity
11/22/2000EP1053306A1 Secreted proteins and polynucleotides encoding them
11/22/2000EP1053256A1 Antibodies to death receptor 4 (dr4) and uses thereof
11/22/2000EP1053253A1 Novel gaba b? receptor dna sequences
11/22/2000EP1053251A1 The aiolos gene
11/22/2000EP1053245A1 45 human secreted proteins
11/22/2000EP1053241A1 Novel dimerizing agents, their production and use
11/22/2000EP1053009A2 Use of heregulin as an epithelial cell growth factor
11/22/2000EP0871885A4 Attachment enhanced 293 cells
11/22/2000CN1274387A HCVE mimotopes of hypervariable region 1 and uses
11/22/2000CN1274386A Genetic control of plant growth and develepmnt
11/22/2000CN1273783A Process for preparing active peptide of soybean protein
11/21/2000US6150588 DNA encoding antimicrobial proteins from impatiens
11/21/2000US6150547 Iron-casein complex hydrolyzate and process for the production thereof
11/21/2000US6150508 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
11/21/2000US6150505 Preparing aqueous solution of fibrinogen, thrombin and factor xiii, before coagulation adding an oil heated to 50-80 degrees celsius to form emulsion, mixing until crosslinked microbeads are formed, isolating beads; glutaraldehyde-free
11/21/2000US6150502 Polypeptides expressed in skin cells
11/21/2000US6150340 RNA-dependent amidotransferase from Staphylococcus aureus
11/21/2000US6150172 Solvent extraction of isotonic or hypotonic aqueous preparation of biological material and increasing lyotropic activity of mixture to separate solvent from preparation to produce solvent containing abnormal prion protein; diagnosis
11/21/2000US6150169 Inserting a coding sequence into a target endogenous gene in a mouse embryonic stem cell genome by transforming with vector having specific dna construct and allowing homologous recombination
11/21/2000US6150165 Polynucleotide which encodes a delta-endotoxin active against coleopteran pests; biological pest control; transgenic plants; treatment of plants and seeds
11/21/2000US6150150 Human brain phosphodiesterase
11/21/2000US6150149 Nucleotide and amino acid sequence; recombinant production; for use in breeding technology of basidiomycetes fungi and plants
11/21/2000US6150139 Preparing bactericide; culturing cells, separating the supernatant, separate bateriocin from supernatant, recover bacteriocin
11/21/2000US6150137 Immunosuppressant target proteins
11/21/2000US6150134 Recombinant microorganism polypeptide; for the diagnosis, treatment and prevention of preferential microorganismal infections; for the purification of recombinant polypeptides
11/21/2000US6150133 Fermentation control
11/21/2000US6150132 Vector coding polypeptides for the diagnosis and treatment of allergies and atherosclerosis; for the prevention of graft ejection and injuries to stem cell caused by anticarcinogenic agents
11/21/2000US6150116 Transcription factor DP-1 antibody
11/21/2000US6150114 Method and reagent for monitoring blood levels of antiplantelet compounds
11/21/2000US6150099 Detecting modulators of transcription factors; incubating transcription factor and modulator in solution, monitor the level of gene expression
11/21/2000US6150093 Unique associated Kaposi's sarcoma virus sequences and uses thereof
11/21/2000US6150087 Non-hepatitis a or b virus polypeptide which is capable of illiciting immune response with hepatitus virus antibodies, for the treatment of and prevention of viral infections
11/21/2000US6149920 Vaccine for immunization, prophylaxis or treatment of a vertebrate at risk of or suffering from brucellosis, wherein said vaccine comprises an attenuated or avirulent strain of an otherwise pathogenic bacteria of the genus brucella
11/21/2000US6149919 Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines
11/21/2000US6149902 Manipulation of non-terminally differentiated cells using the notch pathway
11/21/2000CA1341142C Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
11/16/2000WO2000068690A1 Method for detecting proteins under mutual interaction
11/16/2000WO2000068413A1 Halo- or hydroxy-substituted nocathiacin antibiotics
11/16/2000WO2000068412A1 Preparation containing cell extract for synthesizing cell-free protein and means for synthesizing cell-free protein
11/16/2000WO2000068387A2 Nucleic acids and proteins with interferon-beta activity
11/16/2000WO2000068386A1 Autotaxin variants and uses to treat diseases of metabolism
11/16/2000WO2000068385A2 Novel nucleic acids and proteins with growth hormone activity
11/16/2000WO2000068384A2 NOVEL NUCLEIC ACIDS AND PROTEINS WITH p53 ACTIVITY AND ALTERED TETRAMERIZATION DOMAINS
11/16/2000WO2000068383A2 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
11/16/2000WO2000068381A1 Cytokine receptor mouse zcytor10
11/16/2000WO2000068380A2 Extracellular matrix and adhesion-associated proteins
11/16/2000WO2000068379A1 Methods for treating tumors using antiangiogenic compounds
11/16/2000WO2000068376A1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
11/16/2000WO2000068265A1 Antimicrobial theta defensins and methods of using same
11/16/2000WO2000068262A1 Novel pollen antigen
11/16/2000WO2000068260A1 Methods for protein purification using aqueous two-phase extraction
11/16/2000WO2000068258A2 Compounds exhibiting an antibiotic activity
11/16/2000WO2000068256A1 Cephaibols, novel antiparasitics from acremonium tubakii, method for the production and the utilization thereof
11/16/2000WO2000068249A2 Novel g-protein modulator (gpm) proteins and nucleic acid molecules and uses therefor
11/16/2000WO2000068240A1 NOVEL aroA
11/16/2000WO2000067793A1 Death domain containing receptor 4
11/16/2000WO2000067792A1 Monoclonal antibody directed against cells of human renal cell carcinoma
11/16/2000WO2000067700A2 Recombinant vaccine against botulinum neurotoxin
11/16/2000WO2000067697A2 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells
11/16/2000WO2000047223A3 Viral vaccine
11/16/2000WO2000042191A3 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
11/16/2000WO2000042179A3 Complex-forming proteins
11/16/2000WO2000037639A3 Lymphocytic membrane proteins
11/16/2000WO2000037613A3 Human akt-3
11/16/2000WO2000037025A3 Antibodies to truncated vegf-d and uses thereof
11/16/2000WO2000034784A9 Protein scaffolds for antibody mimics and other binding proteins
11/16/2000WO2000029561A3 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope
11/16/2000WO2000026370A3 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/16/2000WO2000026241A3 Novel compositions and methods of screening for t-cell and b-cell activation modulators
11/16/2000WO2000023466A3 Human rna binding proteins
11/16/2000WO2000022439A3 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections
11/16/2000WO2000020448A3 Nlk1 -interacting proteins
11/16/2000WO2000009549A3 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use
11/16/2000WO2000006717A9 Improved transformation efficiency in phage display through modification of a coat protein
11/16/2000WO2000005375A9 Gbs toxin receptor
11/16/2000DE19919225A1 Tumorassoziiertes Antigen Tumor-associated antigen
11/16/2000DE19919148A1 Von Interleukin 12 abgeleitete Peptid-Homodimere und Peptid-Heterodimere Interleukin 12 derived peptide homodimers and peptide heterodimers
11/16/2000CA2373851A1 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells
11/16/2000CA2373631A1 Monoclonal antibody directed against cells of human renal cell carcinoma
11/16/2000CA2373063A1 Death domain containing receptor 4
11/16/2000CA2373057A1 Preparation containing cell extracts for cell-free protein synthesis and means for synthesizing protein using the preparation
11/16/2000CA2372961A1 Halo- or hydroxy-substituted nocathiacin antibiotics
11/16/2000CA2372881A1 Novel nucleic acids and proteins with p53 activity and altered tetramerization domains
11/16/2000CA2372871A1 Novel nucleic acids and proteins with growth hormone activity
11/16/2000CA2372837A1 Cytokine receptor mouse zcytor10
11/16/2000CA2372821A1 Antimicrobial theta defensins and methods of using same
11/16/2000CA2372815A1 Extracellular matrix and adhesion-associated proteins
11/16/2000CA2372805A1 Autotaxin variants and uses to treat diseases of metabolism
11/16/2000CA2372699A1 Methods for treating tumors using antiangiogenic compounds
11/16/2000CA2372513A1 Methods for protein purification using aqueous two-phase extraction
11/16/2000CA2371902A1 Novel nucleic acids and proteins with interferon-beta activity
11/16/2000CA2371279A1 Recombinant vaccine against botulinum neurotoxin
11/16/2000CA2371193A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
11/15/2000EP1051620A1 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha
1 ... 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 ... 1125